US · Healthcare · Medical Devices
EPS came in at 0.76 against a street estimate of 0.79 — a miss of 3.8%.
Analysts rate Enovis Corp a strong buy (10 buy, 1 hold, 0 sell out of 11) with an average price target of $38.33.
| Fund | Stake |
|---|---|
| BlackRock Inc | 17.23% |
| American Century Companies Inc | 10.59% |
| Vanguard Portfolio Management, LLC | 6.60% |
| Vanguard Capital Management, LLC | 4.43% |
| Rubric Capital Management LP | 4.25% |
| State Street Corp | 4.17% |
| Davenport & Company LLC | 4.06% |
| Hood River Capital Management LLC | 3.05% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 ENOVIS CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Deal size (enterprise value): €155,000,000 • Upfront cash payment to shareholders: €176,000 | 2026-09-01 |
| Quarterly report · Q3 2026 ENOVIS CORPORATION – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Sales Q2 2026: $582.8 million (up 3.2% vs. $564.5 million in Q2 2025) • Net Sales H | 2026-08-06 |
| Results announced · Q3 2026 ENOVIS CORPORATION – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Net Sales: $582.8 million, up 3% reported / 5% organic year-over-year • Q2 | 2026-08-06 |
| Board / officer change · Q2 2026 ENOVIS CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 19, 2026 • 3,650,000 additional shares authorized for issuance unde | 2026-05-19 |
| Quarterly report · Q2 2026 ENOVIS CORPORATION – Q1 2026 10-Q SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Net sales Q1 2026: $589.2 million vs. $558.8 million Q1 2025 | 2026-05-07 |
| Results announced · Q2 2026 ENOVIS CORPORATION Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q1 2026 net sales: $589.2 million, up 5% reported basis, up 3% organic basis vs. Q1 2 | 2026-05-07 |
| Proxy statement · Q2 2026 ENOVIS CORPORATION PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect 10 directors to the Board (Sharon Wienbar, Damien McD | 2026-04-06 |
| Annual report FY2025 ENOVIS CORPORATION – FORM 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market capitalization (as of July 4, 2025): $1.91 billion • Outstandi | 2026-02-26 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Enovis Corp — free to start.
Google PlayApp StoreData updated 2026-09-18.